Tuesday, February 07, 2017 9:15:44 AM
Now we have two talented individuals with a depth of knowledge and experience in manufacturing and selling cremes in Europe and the German market specifically, and now we have a huge connection to Asia via contacts in Korea, Singapore and China. This is HUGE! This is beyond HUGE!
The traditional biotech route to riches is an old, tired formula: IPO at $50 a share, and hope for FDA approval before the money runs out.
OWCP has a new business plan. Sale of safe and effective topical cremes, in EU and Asia, to generate revenue to pay for those expensive FDA trials for ingested medications.
The foresight and thoughtfulness of the OWCP executive team is so damn rare!
So, tell anyone who was on the MMJ sidelines, worried about cannabis being a schedule 1 substance, that OWCP is likely going to pursue markets in Asia by marketing a line of cannabis cremes as "herbal" remedies. Win Win!
Where it's legal, it will be an MMJ creme. Where it's not legal, it will be a herbal creme. Boom!
Multiple revenue streams, incoming!!!
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM